Stefan K. F. Schwabe MD, PhD

Chief Medical Officer and Executive Vice President of Research & Development

Dr. Stefan K. F. Schwabe, MD, Ph.D. has been Chief Medical Officer and Executive Vice President of Research & Development at Supernus Pharmaceuticals, Inc., since July 9, 2012. Dr. Schwabe has more than 20 years of experience in developing pharmaceutical products in the central nervous system (CNS). He served as Chief Operating Officer at DemeRx since 2010. From 2006 to 2010 Dr. Schwabe served as Vice-President for Project Direction for Neurology Projects at Sanofi-Aventis and from 2004 to 2006 he served as the Executive Director, US Clinical Development and Medical Affairs, Neuroscience for Novartis. From 1998 to 2004, Dr. Schwabe served as the Global Project Leader - Topamax for Johnson & Johnson. Dr. Schwabe served as Medical Director at Gabitril & Seroxat in the Health Care Strategy Unit, International Operations for Novo Nordisk, and both International Project Team Leader and International Clinical Team Leader - Trileptal and Scientific Investigator for Ciba-Geigy. Dr. Schwabe also served as Chief Resident, Department of Neurology for the Medical College of Wisconsin in Milwaukee, Wisconsin. Dr. Schwabe received his Bachelor of Science in Chemistry from Florida International University, his M.D. from the Ludwig-Maximilians University in Munich, Germany and his Ph.D./Doctorate from the Department of Toxicology at the Technical University of Munich, Germany.